PURPOSE: Documenting the impact of different types of cancer on daily functioning and well-being is important for understanding burden relative to other chronic medical conditions. This study examined the impact of 10 different cancers and 13 other chronic medical conditions on health-related quality of life. METHODS: Health-related quality of life data were gathered on the Medicare Health Outcomes Survey (MHOS) between 1998 and 2002. Cancer information was ascertained using the National Cancer Institute's surveillance, epidemiology, and end results program and linked to MHOS data. RESULTS: The average SF-6D score was 0.73 (SD = 0.14). Depressive symptoms had the largest unique association with the SF-6D, followed by arthritis of the hip, chronic obstructive pulmonary disease/asthma, stroke, and sciatica. In addition, the majority of cancer types were significantly associated with the SF-6D score, with significant negative weights ranging from -0.01 to -0.02 on the 0-1 health utility scale. Distant stage of cancer was associated with large decrements in the SF-6D ranging from -0.04 (prostate) to -0.08 (female breast). CONCLUSION: A large number of chronic conditions, including cancer, are associated uniquely with decrements in health utility. The cumulative effects of comorbid conditions have substantial impact on daily functioning and well-being of Medicare beneficiaries.
PURPOSE: Documenting the impact of different types of cancer on daily functioning and well-being is important for understanding burden relative to other chronic medical conditions. This study examined the impact of 10 different cancers and 13 other chronic medical conditions on health-related quality of life. METHODS: Health-related quality of life data were gathered on the Medicare Health Outcomes Survey (MHOS) between 1998 and 2002. Cancer information was ascertained using the National Cancer Institute's surveillance, epidemiology, and end results program and linked to MHOS data. RESULTS: The average SF-6D score was 0.73 (SD = 0.14). Depressive symptoms had the largest unique association with the SF-6D, followed by arthritis of the hip, chronic obstructive pulmonary disease/asthma, stroke, and sciatica. In addition, the majority of cancer types were significantly associated with the SF-6D score, with significant negative weights ranging from -0.01 to -0.02 on the 0-1 health utility scale. Distant stage of cancer was associated with large decrements in the SF-6D ranging from -0.04 (prostate) to -0.08 (female breast). CONCLUSION: A large number of chronic conditions, including cancer, are associated uniquely with decrements in health utility. The cumulative effects of comorbid conditions have substantial impact on daily functioning and well-being of Medicare beneficiaries.
Authors: David Feeny; Karen Spritzer; Ron D Hays; Honghu Liu; Theodore G Ganiats; Robert M Kaplan; Mari Palta; Dennis G Fryback Journal: Med Decis Making Date: 2011-10-18 Impact factor: 2.583
Authors: Dinesh Khanna; Daniel E Furst; Weng Kee Wong; Joel Tsevat; Philip J Clements; Grace S Park; Arnold E Postlethwaite; Mansoor Ahmed; Shaari Ginsburg; Ron D Hays Journal: Qual Life Res Date: 2007-04-03 Impact factor: 4.147
Authors: Martina Garau; Koonal K Shah; Anne R Mason; Qing Wang; Adrian Towse; Michael F Drummond Journal: Pharmacoeconomics Date: 2011-08 Impact factor: 4.981
Authors: Nan E Rothrock; Ron D Hays; Karen Spritzer; Susan E Yount; William Riley; David Cella Journal: J Clin Epidemiol Date: 2010-08-05 Impact factor: 6.437
Authors: Ron D Hays; Seongeun Kim; Karen L Spritzer; Robert M Kaplan; Steve Tally; David Feeny; Honghu Liu; Dennis G Fryback Journal: Value Health Date: 2009-05-15 Impact factor: 5.725
Authors: Ashley Wilder Smith; Bryce B Reeve; Keith M Bellizzi; Linda C Harlan; Carrie N Klabunde; Marni Amsellem; Arlene S Bierman; Ron D Hays Journal: Health Care Financ Rev Date: 2008
Authors: Shi-Yi Wang; Sylvia H Hsu; Cary P Gross; Tara Sanft; Amy J Davidoff; Xiaomei Ma; James B Yu Journal: Value Health Date: 2016-04-07 Impact factor: 5.725
Authors: Ron D Hays; Dennis A Revicki; David Feeny; Peter Fayers; Karen L Spritzer; David Cella Journal: Pharmacoeconomics Date: 2016-10 Impact factor: 4.981
Authors: Euijung Ryu; Paul Y Takahashi; Janet E Olson; Matthew A Hathcock; Paul J Novotny; Jyotishman Pathak; Suzette J Bielinski; James R Cerhan; Jeff A Sloan Journal: Health Qual Life Outcomes Date: 2015-07-03 Impact factor: 3.186
Authors: R E Mujica-Mota; M Roberts; G Abel; M Elliott; G Lyratzopoulos; M Roland; J Campbell Journal: Qual Life Res Date: 2014-10-26 Impact factor: 4.147
Authors: Amarbir S Gill; Jess C Mace; Ryan Rimmer; Vijay R Ramakrishnan; Daniel M Beswick; Zachary M Soler; James Manor; Richard R Orlandi; Timothy L Smith; Jeremiah A Alt Journal: Int Forum Allergy Rhinol Date: 2021-07-14 Impact factor: 3.858